Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D 1 : A Population-Based Study
暂无分享,去创建一个
J. Stanford | A. West | J. Fraumeni | S. Mayne | W. Chow | H. Hibshoosh | J. Schoenberg | I. Weinstein | T. Vaughan | H. Risch | N. Arber | M. Gammon | M. Terry | H. Rotterdam | R. Dubrow
[1] J. Stanford,et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer , 2000, Cancer Causes & Control.
[2] G. Piazza,et al. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines , 1998, Breast Cancer Research and Treatment.
[3] K. Kerlikowske,et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.
[4] L. Brinton,et al. Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[5] N. Sharpless,et al. A mouse model of human oral-esophageal cancer. , 2002, The Journal of clinical investigation.
[6] Carissa A. Sanchez,et al. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[7] G. Jenkins,et al. Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma , 2002, The British journal of surgery.
[8] A. Tarnawski,et al. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action , 2002, American Journal of Gastroenterology.
[9] A. Siermann,et al. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling , 2001, Oncogene.
[10] H. Moses,et al. Salicylate-induced Growth Arrest Is Associated with Inhibition of p70s6k and Down-regulation of c-Myc, Cyclin D1, Cyclin A, and Proliferating Cell Nuclear Antigen* , 2000, The Journal of Biological Chemistry.
[11] D. Forman,et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. , 2000, Journal of the National Cancer Institute.
[12] H. Irving. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis , 2000 .
[13] H. Hibshoosh,et al. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach. , 1999, Human pathology.
[14] A. Rustgi,et al. Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium , 1999, Oncogene.
[15] M. Gammon,et al. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] B. Rigas,et al. Sulindac sulfide alters the expression of cyclin proteins in HT‐29 colon adenocarcinoma cells , 1998, International journal of cancer.
[17] W. Thompson,et al. Re: "p53 protein overexpression in relation to risk factors for breast cancer". , 1998, American journal of epidemiology.
[18] M. Gammon,et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] M. Gammon,et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. , 1998, Journal of the National Cancer Institute.
[20] M. Gammon,et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. , 1997, Journal of the National Cancer Institute.
[21] A. Neugut,et al. Increased expression of the cyclin D1 gene in Barrett's esophagus. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[22] B. Dynlacht,et al. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. , 1996, Oncogene.
[23] H. Peterse,et al. p53 protein overexpression in relation to risk factors for breast cancer. , 1996, American journal of epidemiology.
[24] A. Hoes. Case-control studies. , 1995, The Netherlands journal of medicine.
[25] J. Bartek,et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. , 1994, Cancer research.
[26] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[27] Joseph Waksberg,et al. Sampling Methods for Random Digit Dialing , 1978 .